M42 launches proteomics grant competition in collaboration with SomaLogic to foster innovative research in the GCC for the first time
- Initiative encourages researchers within the region to tap into the vast possibilities of proteomics research
- Promotes the utilization of the cutting-edge SomaScan® Assay as a crucial tool for generating high-quality proteomic data in the GCC region to benefit people, not just patients

Dubai, United Arab Emirates. January 31, 2024: M42, a global tech-enabled health powerhouse, has partnered with the US-based biotechnology company SomaLogic to launch a proteomics grant competition, a first in the region, aimed at inspiring researchers to harness the vast potential of proteomics research.
